The role of matrix metalloproteinase-9 in cigarette smoke-induced emphysema

Jeffrey J Atkinson1, Barbara A Lutey, Yoko Suzuki

  • 1Washington University School of Medicine, St. Louis, MO 63110, USA.

Abstract

Insights

Matrix metalloprotease (MMP)-9 does not appear to cause cigarette smoke-induced emphysema in mice or humans. Inhibition of MMP-9 is unlikely to be an effective therapy for this condition.

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Genetics

Background:

  • Matrix metalloprotease (MMP)-9 is an enzyme linked to pulmonary emphysema development.
  • Mouse models indicate excess MMP-9 can cause alveolar destruction.

Purpose of the Study:

  • To investigate the role of MMP-9 in cigarette smoke-induced emphysema.
  • Utilized MMP-9 knockout mice and human samples for analysis.

Main Methods:

  • Analyzed mouse lungs for inflammation and airspace enlargement using a smoke-exposure model.
  • Isolated human macrophage and monocyte mRNA for gene expression analysis.
  • Quantified plasma biomarkers to assess ongoing lung injury.

Main Results:

  • Mice lacking MMP-9 showed similar smoke-induced lung damage as controls.
  • Macrophages are the primary source of MMP-9 in human emphysema.
  • MMP-9 levels in circulating monocytes correlated with emphysema severity but not ongoing lung damage.

Conclusions:

  • MMP-9 is present in emphysematous lungs but not directly correlated with emphysema severity in smokers.
  • Specific MMP-9 inhibition may not be an effective treatment for cigarette smoke-induced emphysema.
  • Findings suggest mechanisms in human smokers may differ from mouse models.

Related Concept Videos

Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...